Company Valuation: NEURONES

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 920.3 950.8 1,062 1,067 1,047 873.8 - -
Change - 3.32% 11.69% 0.47% -1.89% -16.51% - -
Enterprise Value (EV) 1 655.7 679 771.5 747.4 710.1 542.7 510 471.8
Change - 3.56% 13.62% -3.13% -4.99% -23.57% -6.02% -7.49%
P/E 24.5x 21.6x 21.6x 20.3x 20.1x 15.7x 14.1x 12.8x
PBR 2.95x 2.87x 3x 2.82x 2.62x 2.11x 1.99x 1.86x
PEG - 1.2x 1.9x 3.17x -21.71x 1.78x 1.2x 1.2x
Capitalization / Revenue 1.59x 1.43x 1.43x 1.32x 1.22x 0.95x 0.9x 0.86x
EV / Revenue 1.13x 1.02x 1.04x 0.92x 0.83x 0.59x 0.52x 0.46x
EV / EBITDA 8.6x 7.59x 8.33x 7.82x 7.46x 5.27x 4.49x 3.81x
EV / EBIT 10.6x 9.31x 10.2x 9.59x 9.39x 6.57x 5.52x 4.62x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 1 1 1.2 1.3 1.4 1.5 1.6 1.7
Rate of return 2.63% 2.55% 2.74% 2.96% 3.25% 4.09% 4.37% 4.64%
EPS 2 1.55 1.82 2.03 2.16 2.14 2.329 2.598 2.869
Distribution rate 64.5% 54.9% 59.1% 60.2% 65.4% 64.4% 61.6% 59.2%
Net sales 1 579.9 665.4 741.2 810.4 857.2 917.2 972.2 1,021
EBITDA 1 76.28 89.44 92.61 95.58 95.14 103 113.5 123.9
EBIT 1 61.6 72.9 75.9 77.9 75.6 82.55 92.36 102.1
Net income 1 37.7 44.3 49.4 52.5 52.1 56.77 63.33 69.95
Net Debt 1 -264.6 -271.8 -290.4 -319.5 -336.6 -331.1 -363.8 -402
Reference price 2 38.00 39.25 43.75 43.95 43.05 36.65 36.65 36.65
Nbr of stocks (in thousands) 24,218 24,224 24,272 24,274 24,313 23,842 - -
Announcement Date 2/9/22 2/8/23 3/6/24 3/5/25 3/11/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
15.54x0.58x5.17x4.14% 966M
22.36x3.66x12.77x2.98% 214B
21.93x4.63x11.36x0.75% 189B
-145.13x20.19x111.04x-.--% 130B
-622.65x44.3x182.01x-.--% 129B
15.53x1.69x8.87x3.09% 125B
14.06x2.51x9.71x5.73% 80.6B
20.95x5.52x13.56x2.68% 62.61B
23.78x1.97x12.5x1.31% 46.56B
-16.06x7.1x12.07x-.--% 45.27B
Average -64.97x 9.22x 37.90x 2.07% 102.17B
Weighted average by Cap. -83.39x 10.91x 45.58x 1.82%

Y-o-Y evolution of P/E

Valuation ratios - P/E - NEURONES

Historical PBR trend

Valuation ratios - PBR - NEURONES

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - NEURONES

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - NEURONES


Year-on-year evolution of the Yield

Valuation ratios - Yield - NEURONES